Global Preclinical CRO Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 152674
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 116
  • list Pharmaceuticals and Healthcare

A preclinical CRO treatment is likely to offer the knowledge, experience, and skill needed to take a pharmaceutical medical device or product from the drawing board to distribution. The preclinical contract research organizations (CRO) sector has witnessed a period of tremendous development in the past, profiting from quickly growing (R&D) spending. Several pharmaceutical companies have lost revenue owing to growing patent expirations thus encouraging several manufacturers to outsource factors of the drug manufacturing method to CROs to decrease costs. Due to this, CROs are witnessing significant development.

Scope of the Report:

The worldwide market for Preclinical CRO Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Preclinical CRO Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Charles River Laboratories

Laboratory Corporation of America

Envigo

Eurofins Scientific

PRA Health Science

Wuxi AppTec

Medpace

Pharmaceutical Product Development

Paraxel

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Bioanalysis and DMPK Studies

Toxicology Testing

Others

Market Segment by Applications, can be divided into

Biopharmaceutical Companies

Government and Academic Institutes

Medical Device Companies

There are 15 Chapters to deeply display the global Preclinical CRO Treatment market.

Chapter 1, to describe Preclinical CRO Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Preclinical CRO Treatment, with sales, revenue, and price of Preclinical CRO Treatment, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Preclinical CRO Treatment, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Preclinical CRO Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Preclinical CRO Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Preclinical CRO Treatment Introduction

1.2 Market Analysis by Type

1.2.1 Bioanalysis and DMPK Studies

1.2.2 Toxicology Testing

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Biopharmaceutical Companies

1.3.2 Government and Academic Institutes

1.3.3 Medical Device Companies

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Charles River Laboratories

2.1.1 Business Overview

2.1.2 Preclinical CRO Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Charles River Laboratories Preclinical CRO Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Laboratory Corporation of America

2.2.1 Business Overview

2.2.2 Preclinical CRO Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Laboratory Corporation of America Preclinical CRO Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Envigo

2.3.1 Business Overview

2.3.2 Preclinical CRO Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Envigo Preclinical CRO Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Eurofins Scientific

2.4.1 Business Overview

2.4.2 Preclinical CRO Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Eurofins Scientific Preclinical CRO Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 PRA Health Science

2.5.1 Business Overview

2.5.2 Preclinical CRO Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 PRA Health Science Preclinical CRO Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Wuxi AppTec

2.6.1 Business Overview

2.6.2 Preclinical CRO Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Wuxi AppTec Preclinical CRO Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Medpace

2.7.1 Business Overview

2.7.2 Preclinical CRO Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Medpace Preclinical CRO Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Pharmaceutical Product Development

2.8.1 Business Overview

2.8.2 Preclinical CRO Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Pharmaceutical Product Development Preclinical CRO Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Paraxel

2.9.1 Business Overview

2.9.2 Preclinical CRO Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Paraxel Preclinical CRO Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Preclinical CRO Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Preclinical CRO Treatment Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Preclinical CRO Treatment Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Preclinical CRO Treatment Manufacturer Market Share in 2017

3.3.2 Top 6 Preclinical CRO Treatment Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Preclinical CRO Treatment Market Analysis by Regions

4.1 Global Preclinical CRO Treatment Sales, Revenue and Market Share by Regions

4.1.1 Global Preclinical CRO Treatment Sales and Market Share by Regions (2013-2018)

4.1.2 Global Preclinical CRO Treatment Revenue and Market Share by Regions (2013-2018)

4.2 North America Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

4.3 Europe Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

4.5 South America Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

5 North America Preclinical CRO Treatment by Countries

5.1 North America Preclinical CRO Treatment Sales, Revenue and Market Share by Countries

5.1.1 North America Preclinical CRO Treatment Sales and Market Share by Countries (2013-2018)

5.1.2 North America Preclinical CRO Treatment Revenue and Market Share by Countries (2013-2018)

5.2 United States Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

5.3 Canada Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

5.4 Mexico Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

6 Europe Preclinical CRO Treatment by Countries

6.1 Europe Preclinical CRO Treatment Sales, Revenue and Market Share by Countries

6.1.1 Europe Preclinical CRO Treatment Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Preclinical CRO Treatment Revenue and Market Share by Countries (2013-2018)

6.2 Germany Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

6.3 UK Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

6.4 France Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

6.5 Russia Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

6.6 Italy Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

7 Asia-Pacific Preclinical CRO Treatment by Countries

7.1 Asia-Pacific Preclinical CRO Treatment Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Preclinical CRO Treatment Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Preclinical CRO Treatment Revenue and Market Share by Countries (2013-2018)

7.2 China Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

7.3 Japan Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

7.4 Korea Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

7.5 India Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

8 South America Preclinical CRO Treatment by Countries

8.1 South America Preclinical CRO Treatment Sales, Revenue and Market Share by Countries

8.1.1 South America Preclinical CRO Treatment Sales and Market Share by Countries (2013-2018)

8.1.2 South America Preclinical CRO Treatment Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

8.3 Argentina Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

8.4 Colombia Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

9 Middle East and Africa Preclinical CRO Treatment by Countries

9.1 Middle East and Africa Preclinical CRO Treatment Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Preclinical CRO Treatment Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Preclinical CRO Treatment Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

9.3 UAE Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

9.4 Egypt Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

9.5 Nigeria Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

9.6 South Africa Preclinical CRO Treatment Sales and Growth Rate (2013-2018)

10 Global Preclinical CRO Treatment Market Segment by Type

10.1 Global Preclinical CRO Treatment Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Preclinical CRO Treatment Sales and Market Share by Type (2013-2018)

10.1.2 Global Preclinical CRO Treatment Revenue and Market Share by Type (2013-2018)

10.2 Bioanalysis and DMPK Studies Sales Growth and Price

10.2.1 Global Bioanalysis and DMPK Studies Sales Growth (2013-2018)

10.2.2 Global Bioanalysis and DMPK Studies Price (2013-2018)

10.3 Toxicology Testing Sales Growth and Price

10.3.1 Global Toxicology Testing Sales Growth (2013-2018)

10.3.2 Global Toxicology Testing Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global Preclinical CRO Treatment Market Segment by Application

11.1 Global Preclinical CRO Treatment Sales Market Share by Application (2013-2018)

11.2 Biopharmaceutical Companies Sales Growth (2013-2018)

11.3 Government and Academic Institutes Sales Growth (2013-2018)

11.4 Medical Device Companies Sales Growth (2013-2018)

12 Preclinical CRO Treatment Market Forecast (2018-2023)

12.1 Global Preclinical CRO Treatment Sales, Revenue and Growth Rate (2018-2023)

12.2 Preclinical CRO Treatment Market Forecast by Regions (2018-2023)

12.2.1 North America Preclinical CRO Treatment Market Forecast (2018-2023)

12.2.2 Europe Preclinical CRO Treatment Market Forecast (2018-2023)

12.2.3 Asia-Pacific Preclinical CRO Treatment Market Forecast (2018-2023)

12.2.4 South America Preclinical CRO Treatment Market Forecast (2018-2023)

12.2.5 Middle East and Africa Preclinical CRO Treatment Market Forecast (2018-2023)

12.3 Preclinical CRO Treatment Market Forecast by Type (2018-2023)

12.3.1 Global Preclinical CRO Treatment Sales Forecast by Type (2018-2023)

12.3.2 Global Preclinical CRO Treatment Market Share Forecast by Type (2018-2023)

12.4 Preclinical CRO Treatment Market Forecast by Application (2018-2023)

12.4.1 Global Preclinical CRO Treatment Sales Forecast by Application (2018-2023)

12.4.2 Global Preclinical CRO Treatment Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Preclinical CRO Treatment Picture

Table Product Specifications of Preclinical CRO Treatment

Figure Global Sales Market Share of Preclinical CRO Treatment by Types in

Please fill the form below, to recieve the report sample


+1